Noncoding RNAs: Possible Players in the Development of Fluorosis.

Area of Science:

• Molecular Biology
• Epigenetics
• Toxicology

Background:

• Fluorosis pathogenesis involves alterations in Runt-related transcription factor 2 (RUNX2) signaling.
• The epigenetic impact of fluoride exposure, particularly on small noncoding RNAs, remains largely uninvestigated.
• Understanding these molecular mechanisms is crucial for addressing fluorosis development.

Purpose of the Study:

• To investigate the role of short noncoding RNAs, specifically microRNAs (miRNAs) and small nucleolar RNAs (snoRNAs), in fluorosis.
• To explore the impact of sodium fluoride (NaF) on the expression of these noncoding RNAs in human osteosarcoma (HOS) cells.
• To identify potential regulatory relationships between noncoding RNAs and key genes involved in fluorosis.

Main Methods:

• Global expression profiling of miRNAs and snoRNAs in NaF-treated HOS cells.
• Quantitative PCR (qPCR) to validate expression levels.
• In silico hybridization and C/D box analysis to assess regulatory interactions and structural changes.

Main Results:

• miR-124 and miR-155 were identified as potential direct regulators of RUNX2 and RANKL gene expression.
• NaF exposure led to significant alterations in UG dinucleotides and D-box sequences within snoRNAs.
• These findings suggest a novel epigenetic mechanism contributing to fluorosis.

Conclusions:

• miR-124 and miR-155 are implicated as novel molecular players in the pathogenesis of fluorosis.
• Sodium fluoride exposure induces epigenetic changes in snoRNAs, potentially affecting gene regulation.
• This research opens new avenues for understanding and potentially treating fluorosis through noncoding RNA modulation.